This year’s Scancell AGM was held on Tuesday 18th October at the Kassam Stadium (Home to Oxford United FC) which is adjacent to the Oxford Science park. For Investors who are unfamiliar with the company, Scancell (SCLP) are an Aim listed Biopharmaceutical company specialising in developing vaccines for treatment of various types of cancer. The current market cap is approximately £50m with the shares at around 16p/share http://www.scancell.co.uk/home Links to the annual report and AGM resolutions are here: Annual Report: http://www.scancell.co.uk/investors/financial-info AGM Resolutions: http://www.scancell.co.uk/investors/company-docs Link to meeting reports from the two most recent Scancell meetings Oxford Tech AGMs (July 2016): http://tinyurl.com/zrtf5p4 Proactive investor (July 2016): http://tinyurl.com/h59z5lg I would estimate that there were between 40 and 50 ordinary shareholders present for the AGM,
...Not a member? Join today
Joining ShareSoc helps to empower our collective voice in representing investors, but we also offer exclusive benefits:
Member events & Masterclasses
Regular newsletter
Member only on-line Forums / Q&As
Company data and Voting Guidance
Educational resources
Get involved in our activities
Already a member?
Log in to your account to access this content and all of your other ShareSoc membership benefits.